Medios AG (ILM1.DE) is in Healthcare, Medical Distribution, based in Germany, listed on XETRA. Market cap 262.20M EUR. 52-week range 9.98 to 17.44 EUR. Trailing P/E 22.8. Data as of 2026-10-09.
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the ...